{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:04:51Z","timestamp":1794733491725,"version":"4.9.1"},"reference-count":59,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2019,8,27]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastrointestinal (GI) lymphomas comprise a group of distinct clinicopathological entities of B- or T- cell type, with primary gastrointestinal Hodgkin lymphoma being extremely uncommon. The GI tract is the predominant site of extranodal non-Hodgkin lymphoma accounting for 30\u201340% of all extranodal lymphomas. In the Western world, the stomach is the most commonly involved site followed by the small bowel. Several chronic inflammatory and immune-mediated disorders which predispose to accelerated cell turnover may lead to the malignant transformation of gut lymphocytes and ultimately manifest as GI lymphoma. The challenge for the clinical gastroenterologist is that these tumors may have varied presentations, ranging from nonspecific symptoms such as dyspepsia or bloating to abdominal pain, nausea, vomiting, GI bleeding, diarrhea, weight loss or bowel obstruction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We illustrate the range of presentations of GI lymphoma with examples based on consecutive cases evaluated at our institution over a 6-month period. These cases demonstrate how appropriately directed endoscopic evaluation with biopsies has the potential to provide a definitive diagnosis and allow the patient to proceed to definitive therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The GI tract is the most commonly involved site for extranodal lymphoma with the stomach being most frequently involved organ.Chronic\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      infection, celiac disease, inflammatory bowel disease and autoimmune disorders may predispose to GI lymphoma. This heterogenous group of diseases has varied presentations that may mimic several other GI clinico-pathologic entities. GI lymphomas may be diagnosed with appropriately directed endoscopic evaluation coupled with generous tissue sampling and expert pathologic assessment. Management may range from antibiotic therapy, in the case of\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      -associated gastric MALT lymphoma, to chemotherapy with or without radiation and, in rare instances, surgery. There are presently no guidelines to direct endoscopic surveillance of GI lymphomas following treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2019-000320","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T16:45:12Z","timestamp":1568393112000},"page":"e000320","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":70,"title":["Gastrointestinal lymphoma: the new mimic"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-7299","authenticated-orcid":false,"given":"Anusha","family":"Shirwaikar Thomas","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Hepatology and Nutrition, Houston Methodist Hospital, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn","family":"Quigley","sequence":"additional","affiliation":[{"name":"Hepatology and Nutrition, Houston Methodist Hospital, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"2025073012592370000_6.1.e000320.1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-9066-4_66"},{"key":"2025073012592370000_6.1.e000320.2","unstructured":"Akirav EM , Alonso-Gonzalez N , Truman LA . Lymphoid Tissues and Organs. In: Paul WE , ed. Fundamental immunology. 7th edn. Philadelphia: Lippincott Williams and Wilkins, 2013: 47\u201366."},{"key":"2025073012592370000_6.1.e000320.3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609014104"},{"key":"2025073012592370000_6.1.e000320.4","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"2025073012592370000_6.1.e000320.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1113994"},{"key":"2025073012592370000_6.1.e000320.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02481-8"},{"key":"2025073012592370000_6.1.e000320.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70387-7"},{"key":"2025073012592370000_6.1.e000320.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.015"},{"key":"2025073012592370000_6.1.e000320.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.09.016"},{"key":"2025073012592370000_6.1.e000320.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"2025073012592370000_6.1.e000320.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.047"},{"key":"2025073012592370000_6.1.e000320.12","unstructured":"Swerdlow SH . WHO classification of tumours of haematopoietic and lymphoid tissues. revised. 4th edn. Lyon, France: International Agency on Research on Cancer (IARC) Press, 2017."},{"key":"2025073012592370000_6.1.e000320.13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.15.1240"},{"key":"2025073012592370000_6.1.e000320.14","first-page":"209","article-title":"Gastrointestinal lymphomas: morphology, immunophenotype and molecular features","volume":"3","author":"Bautista-Quach","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"2025073012592370000_6.1.e000320.15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/bjc.1993.141","article-title":"Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National lymphoma investigation cases","volume":"67","author":"Morton","year":"1993","journal-title":"Br J Cancer"},{"key":"2025073012592370000_6.1.e000320.16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1751-2980.12234","article-title":"Primary lymphomas in the gastrointestinal tract","volume":"16","author":"Peng","year":"2015","journal-title":"J Dig Dis"},{"key":"2025073012592370000_6.1.e000320.17","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1200\/JCO.2001.19.18.3861","article-title":"Primary Gastrointestinal Non-Hodgkin\u2019s Lymphoma: I. Anatomic and Histologic Distribution, Clinical Features, and Survival Data of 371 Patients Registered in the German Multicenter Study GIT NHL 01\/92","volume":"19","author":"Koch","year":"2001","journal-title":"J Clin Oncol"},{"key":"2025073012592370000_6.1.e000320.18","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.94847"},{"key":"2025073012592370000_6.1.e000320.19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.SMJ.0000100120.49153.3F","article-title":"Primary esophageal lymphoma: a diagnostic challenge in acquired immunodeficiency Syndrome\u2014Two case reports and review","volume":"97","author":"Weeratunge","year":"2004","journal-title":"South Med J"},{"key":"2025073012592370000_6.1.e000320.20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1751-2980.2008.00354.x","article-title":"Primary non-Hodgkin's lymphoma in the esophagus","volume":"9","author":"Zhu","year":"2008","journal-title":"J Dig Dis"},{"key":"2025073012592370000_6.1.e000320.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2014.09.006"},{"key":"2025073012592370000_6.1.e000320.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00651-4"},{"key":"2025073012592370000_6.1.e000320.23","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.1.36"},{"key":"2025073012592370000_6.1.e000320.24","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i4.181"},{"key":"2025073012592370000_6.1.e000320.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(99)70006-4"},{"key":"2025073012592370000_6.1.e000320.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2007.01.003"},{"key":"2025073012592370000_6.1.e000320.27","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11179"},{"key":"2025073012592370000_6.1.e000320.28","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.4105"},{"key":"2025073012592370000_6.1.e000320.29","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1200\/JCO.1994.12.8.1673","article-title":"Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish lymphoma Study Group","volume":"12","author":"d'Amore","year":"1994","journal-title":"J Clin Oncol"},{"key":"2025073012592370000_6.1.e000320.30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1754-9485.2011.02329.x","article-title":"Ct features of peripheral T-cell lymphoma in the gastrointestinal tract in Chinese population and literature review","volume":"56","author":"Zhu","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2025073012592370000_6.1.e000320.31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/jgh.12471","article-title":"Endoscopic and clinical analysis of primary T-cell lymphoma of the gastrointestinal tract according to pathological subtype","volume":"29","author":"Kim","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2025073012592370000_6.1.e000320.32","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.21873\/anticanres.11602","article-title":"Primary Non-Hodgkin\u2019s Lymphoma of the Gallbladder: \u0391 Population-based Analysis","volume":"37","author":"Ayub","year":"2017","journal-title":"Anticancer Res"},{"key":"2025073012592370000_6.1.e000320.33","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220161","article-title":"Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the gallbladder and review of the literature","volume":"82","author":"Honda","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2025073012592370000_6.1.e000320.34","article-title":"Intravascular large B-cell lymphoma presenting with diffuse gallbladder wall thickening: a case report and literature review","volume":"2018","author":"Al-Katib","year":"2018","journal-title":"Case Rep Radiol"},{"key":"2025073012592370000_6.1.e000320.35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.asjsur.2013.09.009","article-title":"Primary non-Hodgkin's lymphoma of the common bile duct: a case report and literature review","volume":"40","author":"Zakaria","year":"2017","journal-title":"Asian J Surg"},{"key":"2025073012592370000_6.1.e000320.36","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1053\/j.gastro.2017.09.003","article-title":"A 59-year-old man with new jaundice","volume":"154","author":"Mouchli","year":"2018","journal-title":"Gastroenterology"},{"key":"2025073012592370000_6.1.e000320.37","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/OTT.S121521","article-title":"Primary pancreatic lymphoma: two case reports and a literature review","volume":"10","author":"Yu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"2025073012592370000_6.1.e000320.38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7869\/tg.239","article-title":"Primary hepatic lymphoma","volume":"36","author":"Kumar Padhan","year":"2015","journal-title":"Trop Gastroenterol"},{"key":"2025073012592370000_6.1.e000320.39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-077982"},{"key":"2025073012592370000_6.1.e000320.40","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.061663"},{"key":"2025073012592370000_6.1.e000320.41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.hoc.2019.03.003","article-title":"Follicular lymphoma: redefining prognosis, current treatment options, and unmet needs","volume":"33","author":"Welaya","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2 Suppl 2","key":"2025073012592370000_6.1.e000320.42","first-page":"11","article-title":"The treatment of indolent lymphomas: watchful waiting V aggressive combined modality treatment","volume":"25","author":"Young","year":"1988","journal-title":"Semin Hematol"},{"key":"2025073012592370000_6.1.e000320.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(03)00002-4"},{"key":"2025073012592370000_6.1.e000320.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.07.017"},{"key":"2025073012592370000_6.1.e000320.45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.dld.2017.12.006","article-title":"Gastrointestinal lymphomas: French intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH)","volume":"50","author":"Matysiak-Budnik","year":"2018","journal-title":"Dig Liver Dis"},{"key":"2025073012592370000_6.1.e000320.46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.beha.2017.01.002","article-title":"Clinical aspects and therapy of gastrointestinal MALT lymphoma","volume":"30","author":"Thieblemont","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"2025073012592370000_6.1.e000320.47","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008206329583"},{"key":"2025073012592370000_6.1.e000320.48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/10428199909058457","article-title":"Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma","volume":"33","author":"Ferrer","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"2025073012592370000_6.1.e000320.49","doi-asserted-by":"crossref","unstructured":"Mishima Y , Terui Y , Yokoyama M , et al . R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma. Exp Hematol Oncol 2012;1.doi:10.1186\/2162-3619-1-30","DOI":"10.1186\/2162-3619-1-30"},{"key":"2025073012592370000_6.1.e000320.50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11605-015-3052-4","article-title":"Primary Gastrointestinal Non-Hodgkin\u2019s Lymphoma of the Small and Large Intestines: a Systematic Review","volume":"20","author":"Lightner","year":"2016","journal-title":"J Gastrointest Surg"},{"key":"2025073012592370000_6.1.e000320.51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.026"},{"key":"2025073012592370000_6.1.e000320.52","first-page":"e83","article-title":"Peripheral T-cell lymphomas: incorporating new developments in diagnostics, prognostication, and treatment into clinical Practice-PART 2: ENKTL, EATL, indolent T-cell LDP of the Gi tract, ATLL, and Hepatosplenic T-cell lymphoma","volume":"32","author":"Zing","year":"2018","journal-title":"Oncology"},{"key":"2025073012592370000_6.1.e000320.53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000369542","article-title":"Enteropathy-associated T-cell lymphoma: improving treatment strategies","volume":"33","author":"Nijeboer","year":"2015","journal-title":"Dig Dis"},{"key":"2025073012592370000_6.1.e000320.54","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/S2352-3026(18)30039-5","article-title":"CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial","volume":"5","author":"Gleeson","year":"2018","journal-title":"Lancet Haematol"},{"key":"2025073012592370000_6.1.e000320.55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijscr.2017.08.058","article-title":"Intestinal perforation that developed after chemotherapy in a patient diagnosed with non-Hodgkin lymphoma: a case report and review of literature","volume":"39","author":"Tatar","year":"2017","journal-title":"Int J Surg Case Rep"},{"key":"2025073012592370000_6.1.e000320.56","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2397430","article-title":"The role of endoscopic ultrasound in the diagnosis and management of primary gastric lymphoma","volume":"2017","author":"Schizas","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"2025073012592370000_6.1.e000320.57","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/2050640618800540","article-title":"Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: consequences for follow-up: celiac disease, lymphoma and Gi carcinoma","volume":"6","author":"van Gils","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"2025073012592370000_6.1.e000320.58","first-page":"405","article-title":"Nodular Lymphoid Hyperplasia of the Gastrointestinal Tract : a comprehensive review","volume":"80","author":"Elkholy","year":"2017","journal-title":"Acta Gastroenterol Belg"},{"key":"2025073012592370000_6.1.e000320.59","doi-asserted-by":"publisher","DOI":"10.4253\/wjge.v6.i11.534"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2019-000320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:59:39Z","timestamp":1753905579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2019-000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,9,13]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bmjgast-2019-000320"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2019-000320","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}